Global Urokinase Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Urokinase market size was valued at USD 46 million in 2022 and is forecast to a readjusted size of USD 65 million by 2029 with a CAGR of 5.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
This report is a detailed and comprehensive analysis for global Urokinase market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Urokinase market size and forecasts, in consumption value ($ Million), sales quantity (BIU), and average selling prices (US$/MIU), 2018-2029
Global Urokinase market size and forecasts by region and country, in consumption value ($ Million), sales quantity (BIU), and average selling prices (US$/MIU), 2018-2029
Global Urokinase market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (BIU), and average selling prices (US$/MIU), 2018-2029
Global Urokinase market shares of main players, shipments in revenue ($ Million), sales quantity (BIU), and ASP (US$/MIU), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Urokinase
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Urokinase market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Syner-Med, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical and Techpool, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Urokinase market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Urokinase Powder
    Urokinase Solution
Market segment by Application
    Hospital
    Clinic
    Others
Major players covered
    Syner-Med
    Wanhua Biochem
    Jiangxi Haoran Bio-Pharma
    Jiangsu Aidea Pharmaceutical
    Techpool
    Microbic Biosystems
    LIVZON
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Urokinase product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Urokinase, with price, sales, revenue and global market share of Urokinase from 2018 to 2023.
Chapter 3, the Urokinase competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Urokinase breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Urokinase market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Urokinase.
Chapter 14 and 15, to describe Urokinase sales channel, distributors, customers, research findings and conclusion.